Qianhai Health Holdings Limited, an investment holding company, engages in the sourcing, wholesaling, and retailing of American ginseng and other products in Hong Kong.
The last earnings update was 53 days ago.
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
Qianhai Health Holdings. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
Qianhai Health Holdings's
is considered below, and whether this is a fair price.
Price based on past earnings
Qianhai Health Holdings's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Qianhai Health Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Retail Distributors industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Qianhai Health Holdings
expected to grow at an
Unable to compare Qianhai Health Holdings's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare Qianhai Health Holdings's earnings growth to the Hong Kong market average as no estimate data is available.
Unable to compare Qianhai Health Holdings's revenue growth to the Hong Kong market average as no estimate data is available.
Unable to determine if Qianhai Health Holdings is high growth as no earnings estimate data is available.
Unable to determine if Qianhai Health Holdings is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
Qianhai Health Holdings's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
Qianhai Health Holdings
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
A company's financial position is much like your own financial position,
it includes everything you own
The boxes below represent the relative size of what makes up
Qianhai Health Holdings's finances.
The net worth of a company is the difference between its assets and liabilities.
Qianhai Health Holdings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Qianhai Health Holdings's cash and other short term assets cover its long term commitments.
This treemap shows a more detailed breakdown of
Qianhai Health Holdings's finances. If any of them are yellow this
indicates they may be out of proportion and red means they relate to one of the
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
Low level of unsold assets.
Debt is covered by short term assets, assets are 2806.9x debt.
Nearly all companies have debt. Debt in itself isn’t
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.
The graphic below shows equity (available funds) and debt, we ideally want to
see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and
whether the level has increased over the past 5 years.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Mr. Huang Guanchao serves as chairman of the Board and the chief executive officer of Qianhai Health Holdings Limited since May 02, 2019. Mr. Huang served as an Executive Director of Qianhai Health Holdings Limited since April 12, 2019 until May 02, 2019. Mr. Huang has over 19 years of management experience in international trading and distribution of electronic components. From 1999 to 2003, Mr. Huang, on his own, operated an electronic components trading company. Subsequently in 2003, Mr. Huang, together with other business partners, founded a Hong Kong-based global electronic components trading and distribution group (the “Trading and Distribution Group”), which supplies electronic components to customers including sizeable manufacturing groups and technology companies. Since the establishment of the Trading and Distribution Group, Mr. Huang has been its Chief Executive Officer, managing its business with presence in Hong Kong, the People’s Republic of China (the “PRC”) and the Southeast Asia. In 2005, Mr. Huang, together with other business partners, established another manufacturing and trading group, which is principally engaged in the manufacturing of semiconductor products of a well-known brand that are sold to different markets including Hong Kong, the PRC, Taiwan and other Asian countries. Mr. Huang has been the standing director of Shenzhen Chao Shan Chamber of Commerce since December 2011.
Insufficient data for Guanchao to compare compensation growth.
Insufficient data for Guanchao to establish whether their remuneration is reasonable compared to companies of similar size in Hong Kong.
Chairman & CEO
CFO & Company Secretary
Kwai Fong Ip
Board of Directors Tenure
Average tenure and age of the
Qianhai Health Holdings
board of directors in years:
The tenure for the Qianhai Health Holdings board of directors is about average.
What Does Qianhai Health Holdings Limited's (HKG:911) PE Ratio Tell You?
Qianhai Health Holdings Limited (HKG:911) is trading with a trailing P/E of 23.7x, which is higher than the industry average of 16.1x. … Although some investors may jump to the conclusion that you should avoid the stock or sell if you own it, understanding the assumptions behind the P/E ratio might change your mind. … See our latest analysis for Qianhai Health Holdings
Will Qianhai Health Holdings Limited (HKG:911) Continue To Underperform Its Industry?
and looking to gauge the potential return on investment in Qianhai Health Holdings Limited (HKG:911). … Qianhai Health Holdings Limited (HKG:911) performed in line with its distributors industry on the basis of its ROE – producing a return of 5.33% relative to the peer average of 6.06% over the past 12 months. … But what is more interesting is whether 911 can sustain or improve on this level of return
Qianhai Health Holdings Limited, an investment holding company, engages in the sourcing, wholesaling, and retailing of American ginseng and other products in Hong Kong. The company operates through Cultivated Ginseng, Wild Ginseng, Ginseng Wine, and Others segments. It offers American ginseng, an herbaceous perennial plant, which includes cultivated and wild American ginseng; provides ginseng wine; and trades in other foods, such as dried cordyceps, dried cubilose, and dried seafood products. The company is also involved in the property and other assets holding, and property leasing activities; provision of administrative services; and hot spring project. The company was formerly known as Hang Fat Ginseng Holdings Company Limited and changed its name to Qianhai Health Holdings Limited in September 2016. The company was founded in 1989 and is based in Sheung Wan, Hong Kong. Qianhai Health Holdings Limited is a subsidiary of Cervera Holdings Limited.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.